Viewing Study NCT00730457


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-29 @ 9:49 PM
Study NCT ID: NCT00730457
Status: COMPLETED
Last Update Posted: 2014-09-23
First Post: 2008-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine
Sponsor: VaxInnate Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module